Clinical trial

Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With…

NCT00003642 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated

Key facts

NCT number NCT00003642
Title Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer
Official title A Phase II Feasibility Study of Combined Accelerated External Radiation and Chemotherapy With 5FU and CDDP Following Transurethral Resection in Patients With Muscle Invasive Transitional Carcinoma of the Bladder - T2-T3, N0, M0 (UICC 1992)
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Bladder Cancer
Intervention type Drug, Radiation
Interventions cisplatin, fluorouracil, radiation therapy
Enrollment 43
Start date Oct 1, 1998
Primary completion Jul 1, 2001
First posted Apr 9, 2004
Last update posted Mar 6, 2012
Countries France, Netherlands

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies